De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.
- 1 January 1989
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 86 (2) , 641-644
- https://doi.org/10.1073/pnas.86.2.641
Abstract
The 89-kDa cell surface glycoprotein, P3.58, is detectable on advanced human melanomas in situ but not on benign melaoncoytes or early melanomas. cDNA cloning of P3.58 from melanoma cells was accomplished by screening a .lambda. zap expression vector library with monoclonal antibodies produced against the denatured antigen. Nucleotide sequencing of the clones revealed that P3.58 is identical to the intercellular-adhesion molecule 1. No qualitative differences in P3.58 mRNA species could be seen between melanoma cells and hematopoietic cells and no differences in gene organization were observed between peripheral blood leukocytes and melanoma cells. Inspection of the deduced amino acid sequence of P3.58 indicated the presence of the consensus sequence characteristic for complement-binding proteins. The acquisition of this cell-adhesion molecule during the process of tumor progression is speculated to contribute to the development of metastasis in melanoma.This publication has 21 references indexed in Scilit:
- Cell Adhesion Molecules in the Regulation of Animal Form and Tissue PatternAnnual Review of Cell Biology, 1986
- Structural analysis of human complement protein H: homology with C4b binding protein, beta 2-glycoprotein I, and the Ba fragment of B2.The Journal of Immunology, 1986
- A molecular mechanism of complement resistance of human melanoma cells.The Journal of Immunology, 1986
- Structure of the Human Interleukin-2 Receptor GeneScience, 1985
- Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement systemBiochemical Journal, 1985
- In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89.The Journal of Experimental Medicine, 1985
- Complete primary structure for the zymogen of human complement factor B.Journal of Biological Chemistry, 1984
- Biological Diversity in Metastatic Neoplasms: Origins and ImplicationsScience, 1982
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970